Â¥
17.74
Nov 29
New Key Statistics Module, Z-Score and F-Score
SZSE:002393 Key Ratios
Market Cap ¥ M | 4,575.91 |
Enterprise Value ¥ M | 2,372.18 |
P/E(ttm) | 24.07 |
PE Ratio without NRI | 21.90 |
Forward PE Ratio | -- |
Price/Book | 0.92 |
Price/Sales | 3.54 |
Price/Free Cash Flow | 27.68 |
Price/Owner Earnings | 35.41 |
Payout Ratio % | 0.74 |
Revenue (TTM) ¥ M | 1,265.00 |
EPS (TTM) ¥ | 0.74 |
Beneish M-Score | -2.52 |
10-y EBITDA Growth Rate % | 2.00 |
5-y EBITDA Growth Rate % | 7.00 |
y-y EBITDA Growth Rate % | -42.80 |
EV-to-EBIT | 10.77 |
EV-to-EBITDA | 10.77 |
PEG | 3.13 |
Shares Outstanding M | 257.94 |
Net Margin (%) | 14.89 |
Operating Margin % | 7.85 |
Pre-tax Margin (%) | 17.17 |
Quick Ratio | 3.70 |
Current Ratio | 4.01 |
ROA % (ttm) | 3.20 |
ROE % (ttm) | 3.86 |
ROIC % (ttm) | 2.78 |
Dividend Yield % | 3.38 |
Altman Z-Score | 3.73 |
SZSE:002393 Number of Guru Trades
SZSE:002393 Volume of Guru Trades
Gurus Latest Trades with SZSE:002393
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:002393 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Tianjin Lisheng Pharmaceutical Co Ltd Insider Transactions
No Available Data